Nadine S Matthie1, Nicholas A Giordano1, Coretta M Jenerette2, Gayenell S Magwood3, Sharon L Leslie4, Emily E Northey1, Caitlin I Webster5, Soumitri Sil6. 1. Nell Hodgson Woodruff School of Nursing, Emory University; Atlanta, GA 30322, USA. 2. College of Nursing, University of South Carolina; Columbia, SC 29208, USA. 3. College of Nursing, Medical University of South Carolina; Charleston, SC 29425, USA. 4. Woodruff Health Sciences Center Library, Emory University; Atlanta, GA 30322, USA. 5. Children's Healthcare of Atlanta; Atlanta, GA 30329, USA. 6. School of Medicine, Emory University; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta; Atlanta, GA 30322, USA.
Abstract
Aim: Characterize use and efficacy/effectiveness of virtual, augmented, or mixed reality (VR/AR/MR) technology as non-pharmacological therapy for chronic pain. Methods: Systematic search of 12 databases to identify empirical studies, of individuals who experience chronic pain or illness involving chronic pain, published between 1990 and 2021. JBI Critical Appraisal Checklists assessed study bias and a narrative synthesis was provided. Results: 46 studies, investigating a total of 1456 participants and including 19 randomized controlled trials (RCT), were reviewed. VR/AR/MR was associated with improved pain-related outcomes in 78% of the RCTs. Conclusion: While most studies showed effects immediately or up to one month post treatment, RCTs are needed to further evaluate VR/AR/MR, establish long-term benefits, and assess accessibility, especially among individuals who experience pain management disparities.
Aim: Characterize use and efficacy/effectiveness of virtual, augmented, or mixed reality (VR/AR/MR) technology as non-pharmacological therapy for chronic pain. Methods: Systematic search of 12 databases to identify empirical studies, of individuals who experience chronic pain or illness involving chronic pain, published between 1990 and 2021. JBI Critical Appraisal Checklists assessed study bias and a narrative synthesis was provided. Results: 46 studies, investigating a total of 1456 participants and including 19 randomized controlled trials (RCT), were reviewed. VR/AR/MR was associated with improved pain-related outcomes in 78% of the RCTs. Conclusion: While most studies showed effects immediately or up to one month post treatment, RCTs are needed to further evaluate VR/AR/MR, establish long-term benefits, and assess accessibility, especially among individuals who experience pain management disparities.
Authors: Marco Solcà; Vibhor Krishna; Nicole Young; Milind Deogaonkar; Bruno Herbelin; Pavo Orepic; Robin Mange; Giulio Rognini; Andrea Serino; Ali Rezai; Olaf Blanke Journal: Pain Date: 2021-06-01 Impact factor: 6.961
Authors: David Schroeder; Fedor Korsakov; Joseph Jolton; Francis J Keefe; Alex Haley; Daniel F Keefe Journal: IEEE Comput Graph Appl Date: 2013 May-Jun Impact factor: 2.088
Authors: Jennifer Zauderer; Marie-Martine Lefèvre-Colau; Élise Davoine; Maryvonne Hocquart; François Rannou; Agnès Roby-Brami; Christelle Nguyen; Alexandra Roren Journal: Ann Phys Rehabil Med Date: 2021-11-18
Authors: Andrea Stevenson Won; Ariana C Barreau; Mark Gaertner; Tristan Stone; Joshua Zhu; Cheng Yao Wang; Sean Mackey Journal: J Med Internet Res Date: 2021-05-26 Impact factor: 5.428